ArticleCancer gene therapy2018
Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer.
Landon Mott et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancer gene therapy2018
Landon Mott et al.PubMed ↗Publisher ↗
No numbers read from the abstract.